| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10008876 | Annals of Allergy, Asthma & Immunology | 2005 | 10 Pages |
Abstract
CysLTs fulfill the criteria for relevant mediators of allergic rhinitis via their diverse effects on immune, inflammatory, and local structural components of disease. By blocking the cysLT1 receptor responsible for most of these effects, LTRAs represent a useful approach to treatment of this important and prevalent disorder.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Marc MD, William R. MD,